PRP has demonstrated efficacy in mid-shaft hypospadias repair by reducing urethral stenosis and post-operative infection rates [21], and in offering protection against recurrent urinary tract infections by improving the expression of cytoskeletal and barrier function proteins, including CD34, Shh, CK20, M2, and M3 [22]. This evidence concerns the gene SHH and urinary tract infection.